Acadian Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $459K | Sell |
|
|||||
|
2025
Q1 | $424K | Buy |
|
|||||
|
2024
Q4 | $269K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $329K | Buy |
|
|||||
|
2023
Q1 | $332K | Sell |
|
|||||
|
2022
Q4 | $760K | Buy |
|
|||||
|
2022
Q3 | $116K | Buy |
|
|||||
|
2022
Q2 | $23K | Sell |
|
|||||
|
2022
Q1 | $91K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $1.63M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $170K | Buy |
|
|||||
|
2019
Q1 | $83K | Sell |
|
|||||
|
2018
Q4 | $219K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $309K | Buy |
|
|||||
|
2017
Q4 | $108K | Sell |
|
|||||
|
2017
Q3 | $206K | Buy |
|